17
Oversold
Moving averages
SMA 200$1.16+56.03%
Company profile
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using a modified vaccinia ankara virus-like particle vaccine platform. The company is headquartered in Smyrna, Georgia.
SectorHealthcare
IndustryBiotechnology
Market cap$21.82M
P/E ratioNone
EPS$-212.16
Beta3.86
Dividend yield0.00%
52-week high$275.88
52-week low$1.84
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 32
VRTX
Vertex Pharmaceuticals Inc
RSI 43
CRSP
CRISPR Therapeutics AG
RSI 27
IOVA
Iovance Biotherapeutics Inc
RSI 31
BYSI
BeyondSpring Inc
RSI 37
KTTA
Pasithea Therapeutics Corp
RSI 53
BCTX
BriaCell Therapeutics Corp - New
RSI 44
BCDA
BioCardia Inc
RSI 34
CRBU
Caribou Biosciences Inc
RSI 22
PHIO
Phio Pharmaceuticals Corp
RSI 28
RSI alerts for GOVX
An email when GOVX closes below RSI 30 or above 70. Nothing else.
Data last updated 13 November 2026 at 3:38 AM EST